A-shares and ambitions: China s path to superpower status citywireselector.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citywireselector.com Daily Mail and Mail on Sunday newspapers.
Yesterday Shanghai Composite Index closed down 0.4% at 3606.75, and over at Shenzhen the main benchmark index rose 0.7%, both trading volumes totaled RMB 1.1 trln, up 21.07% from the previous trading day.
Chinese investors pour billions into stocks on US blacklist
Premium
A woman walks past a bank s electronic board showing the Hong Kong share index at Hong Kong Stock Exchange
(AP)
Chong Koh Ping,
, The Wall Street Journal
Buyers using the Stock Connect trading link have snapped up the equivalent of a net $15.8 billion in Hong Kong shares this year
Share Via
Read Full Story
Investors from mainland China have spent billions of dollars buying beaten-down shares in Hong Kong-listed companies subject to a U.S. government blacklist.
Buyers using a trading link known as Stock Connect have bought the equivalent of a net $15.8 billion in Hong Kong shares in the first nine trading days of this year, according to Wind, with a heavy concentration on stocks targeted by the U.S.
(2)
DJ EQS-News: Highest Target Price Reached HK$8.40 Stable Growth with Promising Prospect, China New Higher Education Group Favored by the Market
EQS-News / 31/12/2020 / 09:44 UTC+8
Immediate release 31 December 2020 (Stock Code: 2001.HK) [1] Highest Target Price Reached HK$8.40 Stable Growth with Promising Prospect, China New Higher Education Group Favored by the Market (31 December 2020 - Hong Kong) China New Higher Education Group Co., Ltd. ( China New Higher Education Group , together with its subsidiaries, collectively referred to as the Group , stock code: 2001. HK) recently announced its annual results for the year ended 31 August 2020. The good performance has attracted the attention of many domestic and foreign securities companies, including Citigroup, Morgan Stanley, DBS, CICC,
Search jobs Ascentage Pharma Officially Included in Shenzhen-Hong Kong Stock Connect Program
SUZHOU, China and ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company was officially included into the Shenzhen-Hong Kong Stock Connect program (the Hong Kong Stock Connect ). This was officially announced by the Shenzhen Stock Exchange ( SZSE ) on December 25, 2020, which has been effective since December 28, 2020. This inclusion is the very first arrangement for the eligible pre-revenue biotech companies listed under Chapter 18A of Hong Kong s Main Board Listing Rules, and complied with the conditions for the inclusion in the Hong Kong Stock Connect.